General Announcement::Submission of Annual Report FY 2018-19

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Sep-2019 22:00:09
Status
New
Announcement Sub Title
Submission of Annual Report FY 2018-19
Announcement Reference
SG190903OTHR0N2S
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Enclosed please find herewith the Annual Report for the Financial Year 2018-2019 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments

GPL_AR_2018_19_SGX.pdf
Total size =12011K